Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fish and Richardson
Farmers Insurance
Cipla
Federal Trade Commission
Colorcon

Generated: July 18, 2019

DrugPatentWatch Database Preview

Patent: 9,163,257

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,163,257
Title:Expression vector and methods of producing high levels of proteins
Abstract: A process for high expression of protein of interest using an expression vector. The process comprises at least the following regulatory elements: a) a CMV promoter, or its functional variants, b) an intron, c) TPL or its functional variants, d) VA genes or functional variants, and e) a bovine growth hormone polyadenylation sequence or functional variants.
Inventor(s): Singh; Arun K. (Gujarat, IN), Goel; Ashish (Gujarat, IN), Mendiratta; Sanjeev K. (Gujarat, IN)
Assignee: Cadila Healthcare Limited (Ahmedabad, IN)
Application Number:11/922,548
Patent Claims:see list of patent claims

Details for Patent 9,163,257

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Try a Free Trial Cadila Healthcare Limited (Ahmedabad, IN) ➤ Try a Free Trial RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Cadila Healthcare Limited (Ahmedabad, IN) ➤ Try a Free Trial RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Try a Free Trial Cadila Healthcare Limited (Ahmedabad, IN) ➤ Try a Free Trial RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Try a Free Trial Cadila Healthcare Limited (Ahmedabad, IN) ➤ Try a Free Trial RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Try a Free Trial Cadila Healthcare Limited (Ahmedabad, IN) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,163,257

Country Patent Number Publication Date
South Africa 200710554 Oct 29, 2008
World Intellectual Property Organization (WIPO) 2007017903 Feb 15, 2007
World Intellectual Property Organization (WIPO) 2007017903 Jun 28, 2007
United States of America 2011212518 Sep 01, 2011
United States of America 2013236957 Sep 12, 2013
United States of America 9260721 Feb 16, 2016
Ukraine 92913 Dec 27, 2010
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
US Department of Justice
Harvard Business School
Healthtrust
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.